In nearly every other sector, businesses build their strategies around a clear customer-company relationship. But in the healthcare and pharmaceutical fields, “customer” is an imprecise term.

Since prescription drugs are taken by more than 45% of African-American persons, 37% of Hispanic persons and 33% of Asian persons, it behooves the pharmaceutical industry to accommodate their distinct needs throughout the drug development process.

Clinical trials are the FDA-mandated process by which pharmaceutical companies confirm that the efficacy and safety of their new drugs make them worthy of government approval, then distribution to the public through the healthcare system.

inVibe has had a busy year; for the fourth year in a row, joining the ranks of the Inc. 5000 list of fastest-growing private companies and merging with the decentralized clinical trial platform, THREAD.

The foundational value of research for marketing goes back to the pioneering work of Daniel Starch in the early 1920s, when data collection, analysis, and reporting were systematized for the first time.

In their reading and networking opportunities, non-tech leaders today may come across a technological term that seems to be in the news all of the time—a.k.a. a tech buzzword.

First-of-its-kind deal in Spectrum's 26-year history further expands the agency's capabilities following back-to-back years of double-digit growth.

New guidance from the FDA will ‘up the ante’ for diversity considerations. Here’s how your company can prepare.

We are happy to report that the state of SONIC Health is strong," declares Alex Walters, an experience strategist and partner at SONIC. "We have incredibly trusting, innovative, and inspiring clients (we like to refer to them as partners). Together, we made 2021 the year of ‘story.’"

In this episode, Fabio Gratton, CEO and Co-Founder of InVibe, which was recently acquired by THREAD Research, discusses how patient voice listening technology is enhancing and disrupting clinical research by making it easier to collect and use patient responses. The result could be more patient-centric trials informed by the actual patient voice.

Thread has acquired technology firm Cureclick, continuing a string of recent acquisitions designed to expand its decentralized trials business. The deal–financial terms of which were not disclosed–was prompted by Costa Mesa, California-based Cureclick’s “crowdsourcing” platform, which is designed to raise awareness about trials and thereby increase participation.

Decentralized clinical trial company THREAD announced Tuesday it has acquired CureClick, a platform for recruiting trial participants. The latest deal is THREAD's third acquisition announcement in less than six months. In January, the company said it had scooped up inVibe, which aims to use patient voice data for research. THREAD also acquired Modus Outcomes, a research design consultancy, in November.

Kathryn Ticknor-Robinson is a sociolinguist and research director at inVibe Labs. As a human-centered design specialist focused on health, pharma, and biotech, Kathryn draws from her background in communication, ethnography, and voice analysis to uncover in-depth insights and make meaningful recommendations to benefit patients and industry.

Leading healthcare marketer continues to reshape brand building with the addition of experienced storyteller who understands how communications impact the corporate world

Fabio Gratton began his career as a Hollywood scriptwriter. There, he learned that storytelling is difficult, but can be made easier by listening to people to discover their innermost needs and desires. And when he co-founded his first healthcare marketing company about 15 years ago, he quickly realized that pharma had an enormous unmet need — listening to patients and their impassioned stories about illness, treatment, and recovery.

The direct recording and analysis of voice ensures that a more diverse range of patients is represented in clinical trials. This is crucial for effective therapeutic outcomes.

“The next frontier for the life-sciences, which I’m privileged to help unlock and energize, is bringing the patient voice front and center into the industry. For far too long the end user of all our products, services and experiences has been neglected and misunderstood. Patients don’t want to be patronized, talked down to or sold to. They are grappling with the burden of their illness — but that challenge doesn’t define them, and their concerns go well beyond the dynamics of their disease. Instead, patients yearn for understanding, open dialogue and a robust connection with like-minded souls who care. The life-sciences industry has an enormous opportunity to empower patients through listening and engagement.” ~Fabio Gratton, CEO, inVibe Labs, PharmaVoice 100

InVibe Labs, a Costa Mesa health tech firm, has been acquired by clinical trial software maker Thread of Cary, N.C. Financial terms of the deal were undisclosed.

Thread, a North Carolina startup focused on decentralized clinical research tech, announced its purchase of voice-powered research company inVibe for an undisclosed sum.

THREAD Research, a company focused on supporting decentralized clinical trials, acquired fellow tech provider inVibe. The acquisition gives THREAD voice-powered research technology and inVibe’s consulting services. Financial details of the deal weren’t disclosed; however, all inVibe employees and its offices will become part of THREAD.

CARY, N.C., Jan. 12, 2022 /PRNewswire/ -- THREAD, a leading technology and service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), today announced that it has acquired inVibe, the leading voice-powered research and insights technology solution for the life sciences and health care industry. THREAD's addition of inVibe's voice research technology and consulting services to its comprehensive decentralized research platform follows the company's acquisition of Modus Outcomes in November 2021.

Inspired by the FDA’s Patient Focused Drug Development (PFDD) guidance, inVibe Labs launched TrialPulse in early 2021. Given inVibe’s previous success with innovative voice market research solutions for commercial pharmaceutical brands, the team saw a unique and compelling opportunity to apply an analogous approach to drug development.

CureClick has successfully applied several never before tried approaches that are changing how the industry operates within the clinical trial recruitment space. By empowering patient ambassadors to candidly share information and experiences of clinical trials across their social networks, CureClick has tapped into the power of peer-to-peer communication to help optimize the drug development process across more than 70 therapeutic areas.

For years, the DTC National Conference has showcased the best in direct-to-consumer Rx marketing. At the heart of DTC is the “Patient Experience,” essentially the sum total of each person’s unique journey from illness to treatment and, if the experience is successful, back to some kind of health or “new normal.”

COSTA MESA, Calif., Nov. 18, 2021 /PRNewswire/ -- inVibe Labs (https://www.invibe.co), a pioneer in the field of voice technology for market research, today announced it ranked 330 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 27th year. inVibe Labs grew 371% during the 2017-2020, three-year period.

Reflections: The most momentous change impacting the life-sciences industry is the gradual realization of “the quantified self.” We have on average 37 trillion cells in our bodies, so imagine the data stored within each of us.

COSTA MESA, Calif., Nov. 2, 2021 /PRNewswire/ -- inVibe Labs (http://www.invibe.co), a pioneer in the field of voice technology for market research, and recently included on the Inc. 5000 list of fastest growing companies for the third year in a row, has successfully introduced TrialPulse, a technology platform that helps integrate patient insights within the drug development process.

Costa Mesa, CA – October 7, 2021 – inVibe Labs (http://www.invibe.co), a pioneer in the field of voice technology for market research, and recently included on the Inc. 5000 list of fastest growing companies for the third year in a row, announced key promotions to resource their significant growth.

PM360 asked experts in engaging with patients how the patient experience can be improved following COVID and what can be done to reach a more diverse set of patients.

COSTA MESA, Calif., Sept. 9, 2021 /PRNewswire/ -- CureClick, the world's first proprietary crowdsourcing platform that matches clinical trials to available patients, today demonstrated its commitment to reshaping the clinical recruitment industry by announcing the appointment of renowned digital health strategist Nico Coetzee to the post of Chief Marketing Officer. Coetzee will guide the team responsible for creating, communicating, and delivering innovative clinical recruitment solutions that drive value for patients and clients, as well as business partners of CureClick.

In recent years, Big Tech has gotten a bad rep. But of course, many tech companies are doing important work making monumental positive changes to society, health, and the environment. To highlight these, we started a new interview series about “Technology Making An Important Positive Social Impact”. We are interviewing leaders of tech companies who are creating or have created a tech product that is helping to make a positive change in people’s lives or the environment. As a part of this series, I had the pleasure of interviewing Fabio Gratton, Co-founder and CEO of inVibe Labs.

In the high-demand, high-service, high-stakes advertising and communications sector of the life-sciences industry, agency executives consistently juggle myriad client priorities, business pressures, and channel opportunities, all the while keeping the creative juices flowing. Some of the industry’s top strategists and creative talents join this month’s Agency Roundtable to raise their voices on what’s hot and what’s not.

Clinical trial recruitment is notoriously difficult. Finding, vetting, qualifying, and managing trial participants is time-consuming and expensive, with numerous obstacles hindering every step of the arduous process. From precise patient identification to compelling behavioral motivation, traditional approaches often fall short and cost pharma companies millions of dollars and months if not years of delays in drug development.

inVibe Labs has adapted many of the sophisticated tools of Big Tech to revolutionize market research for healthcare, including harnessing the power of voice, and in doing so has again joined the ranks of the Inc. 5000 list of fastest-growing private companies. Thanks to filling an ever-growing need for frictionless market research by continuing to innovate and adding more top talent, their three-year growth rate of 371 percent has earned inVibe the rank of #1,295 on the annual list, for the third year in a row.

Big Tech companies have mastered the consumer experience, enabling the likes of Apple, Google, and Amazon to evolve within a few short years from tiny Silicon Valley startups to trillion-dollar market cap behemoths. Through a robust combination of digital profiling, precision targeting, and dynamic engagement, they provide an unprecedented level of personalization, two-way communication, and real-time responsiveness that has transformed all of our lives.

Apple, Microsoft, Amazon, and Google/Alphabet are the first companies to reach market capitalization of over a trillion dollars, with no end in sight for continued exponential growth across the technology sector. At the core of their jaw-dropping success is a revolution in the customer experience, triggered by digital and empowered through data-driven personalization.

Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine.

Irvine-based CureClick and Thread of North Carolina have formed a partnership to improve patient recruitment for clinical trials. CureClick tackles major barriers to clinical trial recruitment, including lack of patient awareness and fear of experimental medication safety, through a community of patient activists and influencers.

As the hype around so-called siteless trials continues unabated, two trial tech firms are joining forces to tap social media influencers to help push more patients into studies. The pair: decentralized clinical research company Thread and trial recruitment firm CureClick. They say their new pact will allow sponsors and contract research organizations to “access the power of patient activist-driven crowdsourcing to improve recruitment” in virtual trials.

Fulfilling a commitment to diversity and inclusion in the Phase 3 COVE Study of the Moderna COVID-19 Vaccine, Moderna enlisted the help of TrialScope, the global leader in clinical trial disclosure and transparency technology, for patient recruitment. Moderna utilized TrialScope Connect, an industry-first patient referral collective that connects sponsors and clinical trial recruitment partners to rapidly find, screen and enroll clinical trial participants.

US and Canada-based recruitment specialist Rare Patient Voice (RPV) has partnered with voice response technology provider inVibe Labs, to launch a platform accessing the opinions of patients and caregivers.

The Carma Project is an organization that creates tools for people to more readily check for recall notices. It has previously developed a mobile app for people to search. Now through a new partnership with the National Safety Council, it's using a proprietary license plate reader to identify and flag recalls on the road.

The National Safety Council (NSC) and safety technology platform Carma Project today announced a collaboration focused on reducing the number of open safety recalls on the road. Moving forward, NSC will deploy Carma's newest recall identification technology as a part of the "Check to Protect" safety initiative.

inVibe Labs is proud for making the Inc. 5000 list of America's fastest-growing companies for the second year in a row. There has never been a more important time to listen. I am deeply grateful to those who have trusted us with the voice of their customers, and the amazing team at inVibe that lives to listen. Learn more at inVibe.

When digital health incubator founder Fabio Gratton hears that someone wants to start a company with a friend, he recommends one specific book.

Many companies, both large and small, do not take the time to talk to customers directly. Before spending large sums of money on developing products, innovators need to be sure that it reflects the voice of the customer (VOC) and what customers want.

Inc presents Book Smart, where we bring to light the books beloved by prominent entrepreneurs, founders, and notable figures across the spectrum of industry. In this episode, Fabio Gratton, CEO of inVibe Labs, talks to our host, Cameron Albert-Deitch, about her Book Smart pick,"The Founder's Dilemmas,” by Noam Wasserman.

A few weeks ago, inVibe Labs’ Head of Listening Beth Baldys had the amazing opportunity to present with Tiffani Shovlin from Taiho Oncology at Intellus Worldwide Virtual Summit 2020. In alignment with the conference themes of using new methodologies to better understand and empathize with physicians and patients, the duo co-presented a recent case study where inVibe’s voice research platform was used to do just that.

Led by our Publicis Health's Chief Patient Officer, Susan Manber, The Voices of the Pandemic project is a collection of research and insights from across the Publicis network and their external partners, including inVibe Labs.

Sonic Health recognized as one of the 2020 Medical Marketing & Media "Up-and-Coming" Agencies to Watch. Focused on combining Hollywood storytelling with startup innovation, Sonic's client roster is largely comprised of rare disease biotech companies looking to infuse emotion in their internal and external communications.

Carma Project on June 4 announced the launch of a program that pays vehicle owners to get their defective Takata airbag replaced.

COSTA MESA, Calif., June 2, 2020 /PRNewswire/ -- Carma Project today announced the launch of a program that pays vehicle owners to get their defective Takata airbag replaced. This program comes at a time when millions of owners continue to drive their vehicles to access essential businesses amid the COVID-19 crisis.

For industries trying to design and sell products — which is to say, all of them — big data is a bit like the Rosetta Stone. In simply going about our lives, we humans generate yottabytes of measurable information. In that huge mass lies latent patterns and the promise of a deeper understanding: Whoever can interpret it properly will unlock the black boxes of human psychology and behavior.

Survey Shows Decline In Medical Care And Increased Anxiety Among Chronic Illness Population Amid COVID-19. The survey was fielded with the assistance of Rare Patient Voice and CureClick, two patient-centric organizations.

In this report In this report, First Analysis explores the dynamic and rapidly evolving array of digital technology solutions related to the drug commercialization process, highlighting numerous promising opportunities in this burgeoning emerging sector.

Industrywide, approximately 500,000 vehicles with potentially critical safety recalls have been checked by the specialized safety outreach programs created by Carma Project, according to first-year data reported by the company today.

For the twelfth year, Med Ad News has chosen new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold. This year’s three profilees are all centered around bleeding-edge technology, including inVibe Labs, a research company that has automated and exponentially accelerated the process of collecting insights from physicians and patients.

When inVibe Labs launched in 2013, the company’s goal was to be an agile healthcare market research platform, eliminating the numerous friction points associated with traditional qualitative research. But they soon evolved into a company that could help organizations better understand their customers by analyzing their voice.

In pharma, our driving focus is how people come together to make decisions about their lives and bodies. These represent some of our most important, most intimate, most life-changing moments: as a result, social scientists, not data scientists, will be key to the future of our industry.

I was fortunate enough to start my career at an agency that was an early adopter in the digital pharma space. We made it our mission to stay ahead of the digital trends, and looked to industries outside of healthcare to inspire our thinking

We work with pharma clients that have offices in Silicon Valley, and in some sense they have already started adopting the “tech” company culture, because they are competing for talent with these companies.

Alchemy's Chief Alchemist Fabio Gratton to join other industry leaders to mentor and judge young entrepreneurs at the Novartis Biome Open Innovation Challenge at Mobile World Congress.

A baker’s dozen of agency leaders break down the trends, pain points, and cultural influences that are impacting their strategies as well as those of their clients.

It might make some drivers a little nervous to see someone taking a picture of their license plate, but Orange County resident Rob Piscopo is actually doing a favor for car owners.

Across our industry, professionals are under increasing pressure not just to produce quality work, but to embrace new technologies (including AI and machine learning) and keep up with changing privacy laws such as GDPR and CCPA—all on more modest budgets and shorter timelines.

Hear SONIC Health's Ross Fetterolf and InVibe Labs' Kathryn Ticknor share their thoughts on "Patient centricity."

What would today’s modern society look like if suddenly people were no longer able to buy things on Amazon, bank online, stream movies on Netflix, or send text messages and photos to their friends and family?

inVibe Labs, a market research innovator dedicated to changing the way life sciences and other industries listen to their customers, today announced it has earned a top spot on the prestigious Inc. 5000 list of fastest growing private companies.

Med Ad News spoke with digital guru Fabio Gratton about the present and future of augmented and virtual reality technologies in pharma and healthcare.

Once upon a time the “family doctor” was a trusted and beloved professional who arguably dispensed as much emotional support as medical advice. The physician-patient relationship was characterized by a spirit of “benign paternalism” where...

Alchemy Factory, a digital health incubator and co-work space focused on helping companies accelerate and commercialize products, today announced that founder and Chief Alchemist Fabio Gratton earned a repeat honor as a member of the PharmaVOICE 100.

The Carma Project relies on so-called ambassadors to use social media, such as Facebook and Twitter, and person-to-person communication, such as emails and text messages, to persuade owners of cars equipped with defective Takata airbags to get them fixed.

Bitmo, a mobile gifting and payment platform that is transforming the $160 billion gift card industry, has partnered with peer-to-peer safety platform Carma Project to deliver an innovative incentive-based program designed exclusively for accelerating consumer response to automotive recalls.

These eight agencies have their sights set on becoming a Top 100 firm, and it won’t be long if they keep up their stellar work.

PM360 introduces you to the people who invest in and help startups succeed, in this case Fabio Gratton.

This past May 8, Health and Human Services Secretary Alex Azar announced a final rule from the Centers for Medicare and Medicaid Services that will require direct-to-consumer television advertisements for prescription pharmaceuticals covered by Medicare or Medicaid to include the list price – the Wholesale Acquisition Cost – if that price is equal to or greater than $35 for a month’s supply or the usual course of therapy.

Listening and interpreting the patient’s views throughout their journey of care is an important and elusive goal. inVibe Labs has developed a lexicon guide for disease states, that helps shed some light on what a patient is saying about their care as they progress through their treatment with their HCP.

Every entrepreneur’s journey is as unique as he or she is. The common denominator: a passion to improve the lives of patients. Hear about Fabio Gratton's journey with one of the companies he helped incubate: inVibe Labs.

The use of technology has become ubiquitous in clinical trials as the industry looks to streamline and improve processes. Hear expert perspective from CureClick CEO Fabio Gratton.

Fabio Gratton (Cofounder and CEO, Sonic Health): "We found a best-in-class partner that has developed a unique technology that captures customer stories and then analyzes their linguistic and acoustic signals to determine how people truly feel when they talk."

Fabio Gratton was a failed Hollywood screenwriter who took a job just to get by at a marketing agency that would eventually become part of FCB. Now 20 plus years later he has left an undeniable mark on healthcare and marketing. It just goes to show: Never doubt someone with a powerful imagination.

Traditional means like postcards and letters aren’t working fast enough to whittle down a backlog of millions of faulty Takata airbags. So Toyota Motor Sales USA has turned to a social media campaign...

The managers at SONIC Health describe their agency: “Once upon a time there was a little indie agency in southern California that set out to discover what world of healthcare would look like through the eyes of story-loving, wine-drinking, marketing misfits.”

SONIC Health's co-founder Ross Fetterolf, inVibe's Head of Research Kathryn Ticknor, and CureClick's CEO Fabio Gratton share their perspectives on important patient trends in PharmaVoice's special edition focused on patients.

Friends and family might have a new way to tell their loved ones about the largest recall in the history of auto safety, and even make some money in the process.

We get it, everybody’s busy. But according to recent data, millions of people are still riding around with Takata airbags that can cause injury and death if they deploy in an accident. It’s easy and free to get them replaced, and a new peer-to-peer safety platform called Carma Project is helping people point their friends and families toward a solution.

It’s the recall campaign from hell and too many people aren’t responding. Toyota Motor North America (TMNA) and Carma Project want to give financial rewards to people who alert family and friends to the potentially life-threatening Takata airbag recall.

Costa Mesa-based Carma Project has paid out nearly $100,000 in incentives in collaboration with auto manufacturer Toyota to users who encourage friends and family to replace potentially deadly airbags.

OC Startups Now periodically run Q&A’s with interesting entrepreneurs, in their own words. Our first is with Fabio Gratton, founder of the Alchemy Factory, a digital health incubator in Costa Mesa. He also founded the Alchemy Fund; he’s looking to bring in some partners to get it up to $500,000 with a focus on companies in the health and wellness space.

Toyota is working on a new project to encourage their customers to get their vehicles checked out. They are collaborating with the Carma Project, giving gift cards to people for spreading information about the recall, and having friends and family get their cars checked.

One of my most satisfying accomplishments has been contributing to the health literacy of cancer patients in the area of clinical trials. In fact, I’m proud to say that I helped two people learn about and get enrolled in a clinical trial for patients with HR+, HER2- breast cancer.

Industry expects movement on drug pricing and access during 2019, but what other trends and events are we likely to see? We asked experts in a range of pharma-adjacent businesses for their predictions, hunches, and informed guesses.

The automaker and a tech startup are offering money to get car owners to replace deadly Takata airbags

Toyota and Carma Project are partnering because people have been too lazy to get their airbags fixed.

PM360 asked experts in the various newest technologies impacting the pharma industry what is important to know in 2018 and beyond.

“[Data] is one of the really difficult things for startups to [access],” said Fabio Gratton, one of the contest judges. “You can’t prove your solution or test your algorithm without doing a study to collect data. So for Novartis to share data with the startups was brilliant.”

Digital health incubator Alchemy Factory is the #7 fastest-growing private company in Orange County, according to the OC Business Journal based on revenue from its top-performing companies: SONIC health, inVibe Labs, and CureClick.

inVibe Labs, the healthcare industry’s leading market research innovator, has just expanded its Philadelphia-based team with the hiring of two healthcare industry veterans, Beth Baldys and Donna Wray.

Gratton presents at Digital Pharma West his perspective on the importance of listening and the power of voice in better understanding and serving patients.

BryteLife was honored to be invited to share its electrolyte-infused club soda with partygoers at The Whalebone Magazine Three-Year-Anniversary Land Voyage at Gurney’s Montauk Yacht Club.

This story is all about introducing digital marketing techniques to clinical trials. This is a critical issue that will only get more important as pharma searches for more niche and rare-disease drugs to improve patients' health.

OC Startups Now periodically run Q&A’s with interesting entrepreneurs, in their own words. Our first is with Fabio Gratton, founder of the Alchemy Factory, a digital health incubator in Costa Mesa. He also founded the Alchemy Fund; he’s looking to bring in some partners to get it up to $500,000 with a focus on companies in the health and wellness space.

Clinical trials are essential to the industry and, as drug development costs continue to rise, they are more important to its growth than ever before. “We've never had this many trials, and there is more complexity,” says Fabio Gratton, cofounder and CEO of CureClick.

Various theories abound regarding how people make decisions, but at the end of the day, they are all just theories. Until we can climb into people’s heads, we have to rely on ​psychological theory as a way to explain and understand what’s going on so that we can motivate our target market into taking desired actions.

The result of today’s on-demand culture is the increasing expectations of consumers to always want more, exactly when they want it. And that means the User Interface (UI) is due for a complete revamp to better meet consumers’ desires. The story of Wendy Walker is just a taste of what the near future will look like for UI.

A beverage company hatched inside the Costa Mesa incubator Alchemy Factory is shipping its first cases and seeking distribution partners.

What just about everybody agrees upon is an urgent need for innovation within the realm of clinical research. In the era of smart science and smarter patients, clinical-trial units continue to struggle with a range of recruitment and access issues.

Carlsbad-based fintech startup Bitmo Inc., which previously aimed to turn its app into the mobile alternative of choice to carrying payment cards, has stripped down the product and turned it into a delivery system for social gifting.

Exactly one year ago, we launched Antidote Match, the first truly patient centric clinical trials search tool (see an example at the bottom of the post).

In the US, healthcare market research firm inVibe Labs has appointed Sunny Shah as Vice President of Insights.

Fabio Gratton, “Chief Alchemist” and founder of Alchemy Fund, is the latest investor to take interest in Bitmo, one of San Diego’s rising fintech startups...

“At CureClick believe that clinical trials are the lifeblood of medical progress. Without research, there are no new treatments; no cures. It is critical that we help each other find, understand, and participate in research, when it makes sense.” - Brian Poeschl, COO, CureClick

This summer, an app called iRewardHealth is running a promotion that will help Bostonians live even healthier lives, and give back to the community in the process.

Alchemy Factory, an incubator focused on helping health and tech startups expedite their product development through capital, infrastructure, mentorship, research and marketing services, has invested $50,000 in Bitmo.

WEGO Health, a network of more than 100,000 patient leaders, today announced it has partnered with CureClick to make patient influencers available through the CureClick clinical trial recruiting platform.

Company Demonstrates Its On-Demand Qualitative Service, the inVibe Interactive Voice Response Platform, at IIeX Health Conference.

A research study on epilepsy with the Apple Watch and ResearchKit at the core of the work has concluded, and is shedding light on seizure triggers, hopefully paving the way for better identification of precursors of the disruptive and dangerous event.

PMBs and health-plan executives haven't always been vocal about the changes set in motion by the shift to outcomes-based pricing. InVibe, with help from Interactive Forums, polled 13 medical or pharmacy directors. Hear their take on several formulary-related issue.

On Tuesday morning, local digital health strategy firm Sonic Health and Costa Mesa based incubator Alchemy Factory held an innovation workshop for the marketing team of a major Fortune 500 pharmaceutical company at the Cove.

At the recent Part 15 FDA hearing on off-label promotion results from two different consumer/patient surveys were presented. The first was presented by John Mack, Editor of Pharma Marketing News and administered by inVibe Research, and the second was presented by Dr. Doris Peter, Principal Investigator, Best Buy Drugs Project at Consumer Reports.

CureClick was honored with a silver award at last night’s MM&M (Medical Marketing & Media) Awards. The annual MM&M Awards showcase the best in creativity and effectiveness in healthcare marketing, communications, and media.

CureClick today announced the launch of CureClick Media, a new media platform that drives quality patient referrals across dozens of diseases and conditions.

CureClick, a privately held digital health company that has developed the world's first crowdsourcing platform engineered to promote clinical trial participation, education and awareness, today announced a commitment to double its network of its cancer Community Ambassadors in response to the company's participation in the Cancer Moonshot Summit hosted by Vice President Joe Biden.

A research study was conducted using the inVibe clinical research platform to assess the relationship between the time since the last FVIII infusion and how protected from bleeding a patient with severe hemophilia A feels. The findings from the study were presented at the 2016 World Federation of Hemophilia congress.

Fabio is a digital health maven because of his ability to solve the toughest innovation-related challenges with enthusiasm rather than resignation. His curious mind and active intellect has enabled him to develop numerous initiatives that are helping patients, entrepreneurs and others globally...

In the Innovation Day keynote presentation, Chief Alchemist of Southern California's first all-health digital incubators will discuss what he believes is the single-most fundamental driver of all human decisions that will utterly change the way you think about health, wealth and death.

Healthcare market research firm inVibe Labs now lets companies pose questions to payors through its automated voice-response research platform.

This paper is an analysis of a discussion lead by group of innovators gathered at Patient Centered Clinical Trials 2015 in a bid to identify and uncover challenges associated with industry-wide patient-centered technology adoption.

“In a world where wearable sensors interface directly with Watson-like systems with dizzying computational horsepower, future doctors are likely to look more like today’s IT personnel: they will be responsible for procuring the most appropriate hardware and software for the human health enterprise, and then helping to configure and maintain it until it’s time for an upgrade.”

National Stroke Association released a new Public Service Announcement (PSA) this week as part of Come Back Strong -- the first national movement to rally for stroke recovery. The PSA has been released in honor of World Stroke Day which is Thursday, October 29.

The topic of patient centricity remains very active in the clinical trials industry, as the concept continues to emerge and evolve. The purpose of this Patient Centered Clinical Trials facilitated by our friends at eyeforpharma virtual roundtable is to (a) better understand the definition of patient centricity, (b) uncover challenges associated with industry wide patient centered technology adoption and (c) how patient centricity/engagement technologies will push the biopharmaceutical industry to change.

National Stroke Association today unveiled Come Back Strong, the first national movement to rally for stroke recovery and ignite a conversation about the #5 cause of death. Despite killing more women each year than breast cancer, stroke remains largely misunderstood when it comes to overall awareness and the opportunity for recovery.

The PharmaVOICE 100 celebrates the individuals behind the companies, products, brands, tools, and services that benefit patients worldwide, we have now recognized more than 1,000 of the industry’s most inspirational leaders from all sectors of the industry.

Treatment Diaries was founded so that patients could anonymously share information about their cancer journey. This sharing of information is so helpful to others going through similar circumstances. The CureClick Ambassador program also shares information with patients. I joined this program so that I could reach out to others via social media and share information about clinical trials.

The Apple Research Kit was introduced several months ago and is making headway in the world of clinical trials, facilitating clinical trial enrollment, navigation and process for patients.

The announcement of Apple's new ResearchKit platform disrupted the world of clinical innovation and provided a glimpse into the future of medical research.

The UK startup says it reaches “millions” of patients online through partnerships with health portals including Healthline, Everyday Health and CenterWatch, as well as patient networks such as WEGO Health and CureClick.

No matter the preparation, resources or rigor applied, there is often an element of marketing that is done in the dark. Even in today’s data-rich, hyper-connected world there is a degree of guesswork resident in the process. Don’t get me wrong, the marketers making these educated guesses are bright people who get it right a lot of the time. But just not all of the time. Absolute confidence in marketing is an elusive beast.

A three-way partnership of CureClick.com, WEGO Health and TrialReach aims to enlist influential patient opinion leaders to accelerate clinical trial recruitment and completion.